Business ❯ Corporate Governance ❯ Financial Reporting

Internal Controls

Material Weaknesses Fraudulent Conduct Investor Relations Misstatements Securities Fraud Misleading Statements Accounting Practices Audit Committees Fraudulent Practices Material Weakness

Kyndryl Investors Face April 13 Deadline to Seek Lead Role in Securities Case

The push follows February disclosures of internal-control failures.

Driven Brands Investors Face May 8 Lead‑Plaintiff Deadline as Firms Press SDNY Securities Case

Driven Brands Investors Face May 8 Deadline in SDNY Securities Class Action Over Restated Results

Law Firms Seek Lead Plaintiff in Lufax Securities Fraud Case

Driven Brands Securities Case Enters Lead-Plaintiff Phase Ahead of May 8 Deadline

New Kyndryl Class Action Filing Expands Investor Window, Alleges Inflated Cash Flow

Kyndryl Investors Face April 13 Deadline to Seek Lead Role in Securities Class Actions

Kyndryl Investors Face April 13 Deadline to Seek Lead Role in Expanding Securities Class Actions

Driven Brands Sued Over Accounting Restatement With Lead‑Plaintiff Deadline Set for May 8

Kyndryl Class Action Moves Forward as Investors Face April 13 Lead-Plaintiff Deadline

Kyndryl Securities Case Draws Flurry of Investor Solicitations Before April 13 Lead‑Plaintiff Deadline

Kyndryl Class Action Moves Forward With April 13 Lead-Plaintiff Deadline

Kyndryl Securities Class Action Centers on Cash Controls as April 13 Lead‑Plaintiff Deadline Nears

Kyndryl Delays 10-Q and Launches Controls Review After SEC Requests as Finance and Legal Chiefs Exit

Nutex Health Class Actions Reach Lead-Plaintiff Deadline as Law Firms Rally Investors

Nutex Investors Face Oct. 21 Deadline in Securities Class Action Over HaloMD and Accounting Claims

Nutex Health Class Action Intensifies Ahead of Oct. 21 Lead‑Plaintiff Deadline

CoreWeave Prepares $2.7 Billion IPO Targeting $26 Billion Valuation